JP2018509909A5 - - Google Patents

Download PDF

Info

Publication number
JP2018509909A5
JP2018509909A5 JP2017548954A JP2017548954A JP2018509909A5 JP 2018509909 A5 JP2018509909 A5 JP 2018509909A5 JP 2017548954 A JP2017548954 A JP 2017548954A JP 2017548954 A JP2017548954 A JP 2017548954A JP 2018509909 A5 JP2018509909 A5 JP 2018509909A5
Authority
JP
Japan
Prior art keywords
seq
cell
item
subject
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017548954A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018509909A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/023095 external-priority patent/WO2016149599A1/en
Publication of JP2018509909A publication Critical patent/JP2018509909A/ja
Publication of JP2018509909A5 publication Critical patent/JP2018509909A5/ja
Pending legal-status Critical Current

Links

JP2017548954A 2015-03-19 2016-03-18 陰イオンチャネルロドプシンの組成物及び使用方法 Pending JP2018509909A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201562135470P 2015-03-19 2015-03-19
US62/135,470 2015-03-19
US201562149812P 2015-04-20 2015-04-20
US62/149,812 2015-04-20
US201562261821P 2015-12-01 2015-12-01
US62/261,821 2015-12-01
PCT/US2016/023095 WO2016149599A1 (en) 2015-03-19 2016-03-18 Compositions and methods for use of anion channel rhodopsins

Publications (2)

Publication Number Publication Date
JP2018509909A JP2018509909A (ja) 2018-04-12
JP2018509909A5 true JP2018509909A5 (enExample) 2019-04-25

Family

ID=56920337

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017548954A Pending JP2018509909A (ja) 2015-03-19 2016-03-18 陰イオンチャネルロドプシンの組成物及び使用方法

Country Status (7)

Country Link
US (1) US10519205B2 (enExample)
EP (1) EP3271376B1 (enExample)
JP (1) JP2018509909A (enExample)
CN (1) CN107531765B (enExample)
AU (1) AU2016232819B2 (enExample)
CA (1) CA2979975A1 (enExample)
WO (1) WO2016149599A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016232819B2 (en) 2015-03-19 2021-10-21 Board Of Regents Of The University Of Texas System Compositions and methods for use of anion channel rhodopsins
WO2018094188A1 (en) * 2016-11-17 2018-05-24 The Board Of Regents Of The University Of Texas System Compositions and methods for use of anion channel rhodopsins
CN111518813B (zh) * 2019-02-03 2023-04-28 武汉纽福斯生物科技有限公司 视紫红质的编码序列、其表达载体构建及其应用
US11598792B2 (en) * 2019-05-09 2023-03-07 Howard Hughes Medical Institute Voltage indicators
WO2021193732A1 (ja) * 2020-03-24 2021-09-30 国立大学法人岩手大学 改変光受容クロライドチャネル
US20220056100A1 (en) * 2020-08-20 2022-02-24 Board Of Regents Of The University Of Texas System Compositions and methods for use of red-shifted anion channel rhodopsins
JP7756391B2 (ja) * 2021-09-27 2025-10-20 国立大学法人岩手大学 改変光受容クロライドチャネル

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US992074A (en) * 1910-08-30 1911-05-09 Edgar J Sick Fountain-brush.
US5827702A (en) 1994-10-31 1998-10-27 Genentech, Inc. Ocular gene therapy
IT237434Y1 (it) 1997-04-17 2000-09-13 Philco Italiana Lavatrice con carrello per il suo spostamento
CA2346262A1 (en) 1998-09-17 2000-03-23 University Of Florida Methods for treatment of degenerative retinal diseases
IT1318566B1 (it) * 2000-06-09 2003-08-27 Fiuotecnica S R L Proteina rodopsino-simile estraibile dal fotorecettore di euglenagracilis applicabile nella realizzazione di dispositivi
WO2002082904A2 (en) 2001-04-13 2002-10-24 The Trustees Of The University Of Pennsylvania Method of treating or retarding the development of blindness
DE10216005A1 (de) 2002-04-11 2003-10-30 Max Planck Gesellschaft Verwendung von biologischen Photorezeptoren als direkt lichtgesteuerte Ionenkanäle
WO2008089003A2 (en) * 2007-01-09 2008-07-24 The Board Of Trustees Of The Leland Stanford Junior University System for optical stimulation of target cells
CA2685900A1 (en) 2006-05-04 2007-11-15 Wayne State University Restoration of visual responses by in vivo delivery of rhodopsin nucleic acids
WO2011019081A1 (ja) 2009-08-10 2011-02-17 国立大学法人東北大学 発現効率が改善された光受容チャネルロドプシン
US20120214188A1 (en) 2010-11-12 2012-08-23 Nathan Klapoetke Light-activated ion channel molecules and uses thereof
WO2014093701A1 (en) 2012-12-12 2014-06-19 The Broad Institute, Inc. Functional genomics using crispr-cas systems, compositions, methods, knock out libraries and applications thereof
SG11201600059QA (en) 2013-07-09 2016-02-26 Harvard College Multiplex rna-guided genome engineering
AU2016232819B2 (en) 2015-03-19 2021-10-21 Board Of Regents Of The University Of Texas System Compositions and methods for use of anion channel rhodopsins

Similar Documents

Publication Publication Date Title
JP2018509909A5 (enExample)
JP7275043B2 (ja) 増大したhATファミリートランスポゾン媒介遺伝子導入ならびに関連する組成物、システムおよび方法
FI3352776T3 (fi) Htt-repressoreita ja niiden käyttötapoja
JP7427208B2 (ja) 視覚機能再生剤又は視覚機能低下予防剤
CN112543808A (zh) 增强的hAT家族转座子介导的基因转移及相关组合物、系统和方法
JP2015521465A5 (enExample)
WO2018172961A1 (en) Gene therapy for the treatment of cngb1-linked retinitis pigmentosa
Korecki et al. Human MiniPromoters for ocular-rAAV expression in ON bipolar, cone, corneal, endothelial, Müller glial, and PAX6 cells
JP7416406B2 (ja) 機能的ミエリン産生を増進させるための方法および組成物
US20210054370A1 (en) Methods and compositions for treating angelman syndrome
JP2020073536A5 (enExample)
US20250099554A1 (en) Compositions and methods of fas inhibition
US20220290177A1 (en) Compositions and methods for excision with single grna
JP2018537089A5 (enExample)
JP2017527558A5 (enExample)
JP7380670B2 (ja) Igf-1-暗号化dna作製物及びhgf-暗号化dna作製物を用いた神経病症治療
JP2004532844A (ja) イオントホレシスのステップを含む方法により送達されるキメラオリゴヌクレオチドでの遺伝子療法
JPH09501057A (ja) 新規のオリゴヌクレオチド相互作用による血管細胞接着分子の発現の調節
US20220290157A1 (en) Compositions and methods for treating amyotrophic lateral sclerosis
US20220333107A1 (en) Vasculogenic fibroblasts
CN110904046B (zh) Islr基因在制备治疗肥胖及改善胰岛素抵抗的药物中的应用
US20240216537A1 (en) Gene therapy for neuroprotection
CN117377482A (zh) 用于神经保护的基因疗法
WO2013022829A2 (en) Endomucin as an anti-inflammatory agent
JPWO2023051802A5 (enExample)